Large-scale testing (Phase 3)Study completedNCT03316300
What this trial is testing
Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A
Who this might be right for
Macular Telangiectasia Type 2 (MacTel)
Neurotech Pharmaceuticals 120